Advertisement
Australia markets close in 2 hours 13 minutes

  • ALL ORDS

    8,356.70
    +33.20 (+0.40%)
     

  • ASX 200

    8,134.50
    +34.60 (+0.43%)
     

  • AUD/USD

    0.6728
    +0.0021 (+0.32%)
     

  • OIL

    68.83
    +0.18 (+0.26%)
     

  • GOLD

    2,613.60
    +2.90 (+0.11%)
     

  • Bitcoin AUD

    87,088.07
    -2,349.88 (-2.63%)
     

  • XRP AUD

    0.84
    -0.03 (-3.45%)
     

  • AUD/EUR

    0.6056
    +0.0005 (+0.09%)
     

  • AUD/NZD

    1.0886
    +0.0002 (+0.02%)
     

  • NZX 50

    12,704.92
    -127.63 (-0.99%)
     

  • NASDAQ

    19,514.58
    +91.48 (+0.47%)
     

  • FTSE

    8,273.09
    +32.12 (+0.39%)
     

  • Dow Jones

    41,393.78
    +296.98 (+0.72%)
     

  • DAX

    18,699.40
    +181.00 (+0.98%)
     

  • Hang Seng

    17,324.22
    -44.87 (-0.26%)
     

  • NIKKEI 225

    36,581.76
    -251.54 (-0.68%)
     

Penumbra, Inc. to Present at the Canaccord Genuity Growth Conference

PR Newswire
·1-min read

ALAMEDA, Calif., Aug. 2, 2024 /PRNewswire/ -- Penumbra, Inc. (NYSE: PEN) today announced that its management team is scheduled to present at the Canaccord Genuity Growth Conference on Tuesday, August 13, 2024.

Penumbra, Inc. Logo (PRNewsFoto/Penumbra, Inc.)
Penumbra, Inc. Logo (PRNewsFoto/Penumbra, Inc.)

Event:     Canaccord Genuity Growth Conference
Date:       Tuesday, August 13, 2024
Time:       9:00am ET/6:00am PT

A webcast of the presentation can be accessed on the "Events and Presentations" section under the "Investors" tab of the company's website at www.penumbrainc.com. The webcast will be available on the company's website for at least two weeks following the event.

About Penumbra
Penumbra, Inc., the world's leading thrombectomy company, is focused on developing the most innovative technologies for challenging medical conditions such as ischemic stroke, venous thromboembolism such as pulmonary embolism, and acute limb ischemia. Our broad portfolio, which includes computer assisted vacuum thrombectomy (CAVT), centers on removing blood clots from head-to-toe with speed, safety and simplicity. By pioneering these innovations, we support healthcare providers, hospitals and clinics in more than 100 countries, working to improve patient outcomes and quality of life. For more information, visit www.penumbrainc.com and connect on Instagram, LinkedIn and X.

Investor Relations
Penumbra, Inc.
investors@penumbrainc.com

Cision
Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/penumbra-inc-to-present-at-the-canaccord-genuity-growth-conference-302213644.html

SOURCE Penumbra, Inc.